Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v5-FR
Language English French
Date Updated 2023-01-10 2022-12-05
Drug Identification Number 02387743 02387743
Brand name DEXAMETHASONE OMEGA UNIDOSE DEXAMETHASONE OMEGA UNIDOSE
Common or Proper name DEXAMETHASONE, 10 MG/ML (10 MG/1 ML), INJ, PRESERVATIVE FREE DEXAMETHASONE, 10 MG/ML (10 MG/1 ML), INJ, PRESERVATIVE FREE
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients DEXAMETHASONE PHOSPHATE DEXAMETHASONE PHOSPHATE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR
Packaging size 1 mL Vial/ Fiole 1 mL Vial/ Fiole
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-12-04
Actual start date 2022-12-05 2022-12-05
Estimated end date 2023-01-09 2023-01-09
Actual end date 2023-01-09
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments